Thu, Oct 2, 2014, 10:40 AM EDT - U.S. Markets close in 5 hrs 20 mins


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Oct 25, 2012 12:22 PM Flag

    500 Nov 14 puts trade

    Could be a sign that someone knows the contract terms and they're not good. Seen this show before, not looking forward to Friday, I have a bad feeling in my gut. If the revenue numbers are below 5%, IMO the reaction will not be good. If the low end starts at 5% and IMGN will earn high single digits for largeer sales amounts, it could be a plus. For some reason, I am becoming accustomed to being dissapointed by IMGN management, not a good thing.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • One thing that does puzzle me however is that fact that they chose 8AM before the market opens. Why not 4:01 pm after the market closes and the weekend there would be less impact on the share price.

      Maybe that guy Oppy has been right all along. Mitch and Junus are only looking out for themselves and give little information to shareholders. I remember several years ago one of their key people left the company and it was very strange.

      If the shares tank, this group needs to be investigated for giving out inside information.

      • 1 Reply to boeblingenbud
      • Would it have anything to do with priority review decision? Tomorrow is 60 day post submission so Roche should hear from FDA. If no news from FDA then it would most likely be standard review, and that could be taken negatively considering that FDA should have had plenty of time to look at most of the data. I would definitely be worried if there's no FDA news tomorrow.

10.33-0.12(-1.15%)10:40 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.